Wells Fargo analyst Larry Biegelsen notes that the New York Times reports that the White House plans to announce a proposal to expand access to in vitro fertilization, which the firm views as a positive for Cooper Companies (COO). While the firm expects Cooper’s IVF performance to stay pressured in Q4 due to tough comps, it thinks the new reported policy should strengthen the longer-term IVF market growth outlook. The firm keeps an Overweight rating and $72 price target on Cooper shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COO: